SUMMARY

OncologySTAT Editorial Team

Chemotherapy-induced anemia is a common occurrence in patients with cancer who are treated with chemotherapy. Although erythropoiesis-stimulating agents (ESAs) are effective therapy for management of chemotherapy-induced anemia, their use is controversial because of concerns regarding reduced overall survival. This review article examines the most recent evidence on the use of ESAs in patients with cancer as derived from randomized clinical trials and a Cochrane meta-analysis. Based on this evidence,...